Larry M. Simonsmeier Writing Award
The American Society for Pharmacy Law (ASPL) is a nationwide organization with the purposes of: (i) furthering knowledge in the law related to pharmacists, pharmacies, the provision of pharmaceutical care, the manufacturing and distribution of drugs, and other food, drug, and medical device policy issues ("Pharmacy Law"); (ii) communicating accurate legal educational information; and (iii) providing education opportunities for pharmacists, attorneys, and others who are interested in Pharmacy Law.
ASPL recognizes outstanding scholarship related to Pharmacy Law with the Simonsmeier Award. The Award recognizes an outstanding paper relating to the interests of ASPL published during the prior two years (2012-2014). The 2015 Award includes an honorarium plus support for travel to the ASPL Developments in Pharmacy Law Seminar XXVI in Miami, Florida, November 12-15, 2015.
The Award is named in honor of the late Larry Simonsmeier (1944-2009), who was a pharmacist and attorney, professor and dean of Washington State University College of Pharmacy, president of ASPL, and editor of the Rx Ipsa Loquitur for more than twenty years.
Papers related to Pharmacy Law, as defined above, published in or accepted for publication in any English-language peer-reviewed journal (including law reviews) during the period from January 2013 through December 2014 are eligible. Interested parties are invited to nominate published papers written by themselves or other authors. Authors may submit manuscripts that are in press.
Submission of Nominations
Nominations should provide the name, address, daytime telephone number, and e-mail address of the nominator, a reprint of the full paper, and a complete journal citation for the paper being nominated. If an author is submitting a manuscript that is in press, the copy of the manuscript should be accompanied by documentation from the journal editor of the status of the paper, and should include contact information for the journal editor. The deadline for submission of nominations for the Larry M. Simonsmeier Award is June 30, 2015.
Nominations should be addressed to:
Education & Scholarship Committee
Questions may be directed to ASPL at:
Supreme Court upholds states’ use of midazolam as execution drug
On June 29, by a 5-4 majority, the United States Supreme Court refused to ban states’ use of midazolam in executions. The opinion, written by Justice Alito and joined by Justices Roberts, Scalia, Kennedy, and Thomas, held that Oklahoma could continue to use midazolam as part of its execution protocol, finding that petitioner Richard Glossip had failed to “identify a known and available alternative method of execution that entails a lesser risk of pain,” and failed to show that a large dose of midazolam “entails a substantial risk of severe pain.” Writing for the minority, Justice Sotomayor opined that the Court’s ruling would permit prisoners to be “drawn and quartered, slowly tortured to death, or actually burned at the stake” by states. A separate dissent by Justices Breyer and Ginsburg argued that it is “highly likely the death penalty violates the Eighth Amendment,” in part because it is now “unusual” and “imposed arbitrarily.” [Glossip v. Gross, No. 14-7955, S.Ct., 576 U.S. _____ (2015), June 29, 2015; http://bit.ly/1LQPOA7]
AFFORDABLE CARE ACT
Supreme Court sustains Affordable Care Act in King v. Burwell ruling
On June 25, the U.S. Supreme Court ruled 6-3 that tax credits under the Affordable Care Act are available to individuals in states that have a federally-run insurance exchange, thus disposing of the latest challenge to the ACA’s legality. Read More
SAVE THE DATE!
2015 DPLXXVI Seminar
November 12-15, 2015